Trial-centered Patient Cohort Identification | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Algorithm | Evaluation Metrics | |||||||||
WL | 95% CI | P[%] | Sp[%] | PV* | Â | Â | Â | Â | Â | |
Demographics-based Filter | 163 | 149-179 | 1.9 | 24.3 | 8.30E-21 | Â | Â | Â | Â | Â |
DX/ICD-9 | 50 | 35-64 | 6.20 | 78.1 | 5.27E-4 | Â | Â | Â | Â | Â |
NOTE | 28 | 16-41 | 10.7 | 87.9 | 7.75E-2 | Â | Â | Â | Â | Â |
DX/ICD-9+NOTE | 24 | 14-35 | 12.6 | 89.9 | N/A | Â | Â | Â | Â | Â |
Patient-centered Trial Recommendation | ||||||||||
Algorithm | Evaluation Metrics | |||||||||
Sub-population case (127 patients) | Full-population case (215 patients) | |||||||||
WL | 95% CI | P[%] | Sp[%] | PV* | WL | 95% CI | P[%] | Sp[%] | PV* | |
Demographics-based Filter | 42 | 40-43 | 3.2 | 25.5 | 1.7E-143 | 42 | 40-43 | 1.9 | 24.3 | 1.5E-39 |
DX/ICD-9 | 8 | 6-10 | 16.8 | 87.8 | 2.36E-7 | 22 | 19-25 | 3.6 | 60.7 | 3.85E-7 |
NOTE | 4 | 3-5 | 33.1 | 95.0 | 2.54E-2 | 20 | 17-23 | 3.9 | 64.9 | 2.54E-2 |
DX/ICD-9+NOTE | 3 | 3-4 | 35.7 | 95.5 | N/A | 19 | 17-22 | 4.0 | 65.5 | N/A |